Freestone Grove Partners’s C.H. Robinson CHRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Buy
1,080
+1,067
+8,208% +$190K ﹤0.01% 792
2026
Q1
$2.16K Sell
13
-133,243
-100% -$23.8M ﹤0.01% 879
2025
Q4
$21.4M Sell
133,256
-165,565
-55% -$24.5M 0.15% 197
2025
Q3
$39.6M Buy
298,821
+138,916
+87% +$16.3M 0.3% 124
2025
Q2
$15.3M Buy
159,905
+2,108
+1% +$198K 0.12% 232
2025
Q1
$16.2M Buy
+157,797
New +$15.9M 0.17% 183

Other funds holding CHRW

Freestone Grove Partners's CHRW Position: Q2 2026 in Review

Freestone Grove Partners increased its C.H. Robinson (CHRW) stake by 8,208% in Q2 2026, buying an estimated $190K and bringing the position to 1,080 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #792.

Freestone Grove Partners first reported a position in CHRW in Q1 2025 and has held it in 6 quarters since. The position peaked at $39.6M in Q3 2025. 891 funds tracked by Wall St. Rank hold CHRW as of Q2 2026.

  • Freestone Grove Partners held 1,080 shares of C.H. Robinson worth $203K as of Q2 2026.
  • Freestone Grove Partners bought 1,067 C.H. Robinson shares in Q2 2026, an estimated $190K.
  • C.H. Robinson made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #792 holding.
  • Freestone Grove Partners first reported a position in C.H. Robinson in Q1 2025 and has held it in 6 quarters since.
  • Freestone Grove Partners's C.H. Robinson position peaked at $39.6M in Q3 2025.
  • 891 funds tracked by Wall St. Rank held C.H. Robinson as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.